MedinCell S.A. (LON:0ACH)

MedinCell Statistics

Total Valuation

MedinCell has a market cap or net worth of GBP 699.01 million. The enterprise value is 716.50 million.

Market Cap	699.01M
Enterprise Value	716.50M

Important Dates

The next estimated earnings date is Tuesday, June 16, 2026.

Earnings Date	Jun 16, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	33.10M
Shares Outstanding	n/a
Shares Change (YoY)	+8.92%
Shares Change (QoQ)	+9.66%
Owned by Insiders (%)	12.52%
Owned by Institutions (%)	24.01%
Float	25.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	24.69
PB Ratio	-26.14
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-41.15
EV / Sales	25.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-46.43

Financial Position

The company has a current ratio of 2.88

Current Ratio	2.88
Quick Ratio	2.83
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-4.16
Interest Coverage	-1.84

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-9.16%
Return on Invested Capital (ROIC)	-21.03%
Return on Capital Employed (ROCE)	-18.36%
Weighted Average Cost of Capital (WACC)	9.71%
Revenue Per Employee	195,274
Profits Per Employee	-120,082
Employee Count	145
Asset Turnover	0.49
Inventory Turnover	n/a

Taxes

In the past 12 months, MedinCell has paid 32,296 in taxes.

Income Tax	32,296
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +56.87% in the last 52 weeks. The beta is 1.06, so MedinCell's price volatility has been similar to the market average.

Beta (5Y)	1.06
52-Week Price Change	+56.87%
50-Day Moving Average	25.74
200-Day Moving Average	22.38
Relative Strength Index (RSI)	41.47
Average Volume (20 Days)	16,035

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedinCell had revenue of GBP 28.31 million and -17.41 million in losses. Loss per share was -0.55.

Revenue	28.31M
Gross Profit	28.31M
Operating Income	-8.53M
Pretax Income	-17.38M
Net Income	-17.41M
EBITDA	-8.35M
EBIT	-8.53M
Loss Per Share	-0.55

Balance Sheet

The company has 46.70 million in cash and 64.23 million in debt, with a net cash position of -17.53 million.

Cash & Cash Equivalents	46.70M
Total Debt	64.23M
Net Cash	-17.53M
Net Cash Per Share	n/a
Equity (Book Value)	-26.74M
Book Value Per Share	-0.81
Working Capital	34.94M

Cash Flow

In the last 12 months, operating cash flow was -14.75 million and capital expenditures -682,578, giving a free cash flow of -15.43 million.

Operating Cash Flow	-14.75M
Capital Expenditures	-682,578
Free Cash Flow	-15.43M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -30.14% and -61.49%.

Gross Margin	100.00%
Operating Margin	-30.14%
Pretax Margin	-61.38%
Profit Margin	-61.49%
EBITDA Margin	-29.50%
EBIT Margin	-30.14%
FCF Margin	n/a

Dividends & Yields

MedinCell does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.92%
Shareholder Yield	-8.92%
Earnings Yield	-2.49%
FCF Yield	-2.21%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MedinCell has an Altman Z-Score of 3.26 and a Piotroski F-Score of 3.

Altman Z-Score	3.26
Piotroski F-Score	3